Ingrid Zerbe - 07 Jul 2022 Form 4 Insider Report for IntelGenx Technologies Corp.

Reporting relationship: Corporate Secretary
Issuer ticker: N/A
Reported as of: 07 Jul 2022
Net transaction value: +$81,352
SEC form: 4
Accepted by SEC: 08 Jul 2022, 16:15:36 UTC
Next SEC filing: 31 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Ingrid Zerbe

Key filing fact

Ingrid Zerbe filed Form 4 for IntelGenx Technologies Corp. on 08 Jul 2022.

Key facts

This page summarizes Ingrid Zerbe's Form 4 filing for IntelGenx Technologies Corp..
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 08 Jul 2022, 16:15.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$81,352.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IGXT transaction

Common Stock, 0.00001 p.V.

Other

Transaction value: $78,236
Shares: +355,618
Change %: +111%
Price: $0.2200
Shares after: 674,712
Date: 07 Jul 2022
Ownership: Direct
Footnotes: F1

IGXT transaction

Common Stock, 0.00001 p.V.

Other

Transaction value: $3,116
Shares: +10,526
Change %: +1.6%
Price: $0.2960
Shares after: 685,238
Date: 07 Jul 2022
Ownership: Direct
Footnotes: F2

IGXT holding

Common Stock, 0.00001 p.V.

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,158,221
Date: 07 Jul 2022
Ownership: See footnote
Footnotes: F3

IGXT holding

Common Stock, 0.00001 p.V.

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,158,221
Date: 07 Jul 2022
Ownership: See footnote
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IGXT transaction Derivative

8% 2017 Convertible Debenture

Other

Transaction value: $0
Shares: -100,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 07 Jul 2022
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 355,618
Exercise price: $0.2200
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Note: shares received in lieu of cash re-payment for 2017 Convertible Debenture at maturity June 30, 2022. Applied share price C$0.2812 per share as per indenture.

Footnote F2

Note: shares received in lieu of cash interest payment due June 30, 2022 on IGXT 2017 Convertible Debenture. Applied share price C$0.38 per share.

Footnote F3

In connection with the acquisition of IntelGenx in 2006, Ingrid Zerbe became our Corporate Secretary and Director of Finance and Administration and acquired 4,709,643.5 exchangeable Shares of our Canadian holding corporation 6544631Canada Inc., a Canadian special purpose corporation which wholly owns IntelGenx Corp. (the "Exchangeable Shares"). In June of 2009 Ms. Zerbe acquired 1,021,713 Exchangeable Shares from Joel Cohen in a private transaction. The 5,731,356.5 Exchangeable Shares are exchangeable, on a one for one basis, into shares of common stock of IntelGenx Technologies Corp. at Ms. Zerbe's discretion. As of today 573,135 exchangeable shares have been exchanged into common stock of IntelGenx Technologies Corp. Prior to exchanging the remaining Exchangeable Shares, Ms. Zerbe has the right to vote 5,158,221.5 shares of common stock which are currently held in trust on behalf of Ms. Zerbe. The common shares have not been registered for resale at this time.

Footnote F4

Note: Debenture converted for shares in lieu of cash re-payment at maturity June 30, 2022. Applied share price C$0.2812 per share as per indenture.